Illumina Says Rival Infringes DNA Sequencing IP At Trial Start
An American company behind a system for rapid DNA sequencing for medical research defended its patents' validity Monday as it kicked off its London infringement trial against a Chinese rival....To view the full article, register now.
Already a subscriber? Click here to view full article